Regrettably, this study did not measure the circulatory level of thrombospondin-1 (TSP1), a natural inhibitor of neovascularization, notably increased in the platelet-poor plasma of aged adults, and those with cardiovascular and metabolic disease [31]. Here, THBS1 is linked to Other metabolic disease.